()
 
 

Overview

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three large, unmet medical needs -- Alzheimer's disease, Huntington's disease and hormone-refractory prostate cancer. For more information, please go to http://www.medivation.com.


Contact Information

55 Hawthorne Street
Suite 610
San Francisco, CA 94105

tel: 415-543-3470
fax: 415-543-3411
http://www.medivation.net

,  



Investor Relations



tel:
fax:




Stock

Exchange: NASDAQ
Industry: Biotechnology
Market Cap: $424.3M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.